SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12G - Securities registration termination [Section 12(g)]:
SEC Accession No. 0001640455-23-000117
Filing Date
2023-05-15
Accepted
2023-05-15 07:40:24
Documents
1
Effectiveness Date
2023-05-15

Document Format Files

Seq Description Document Type Size
1 15-12G jnce05152023form15.htm 15-12G 13264
  Complete submission text file 0001640455-23-000117.txt   14254
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12G | Act: 34 | File No.: 001-37998 | Film No.: 23918420
SIC: 2836 Biological Products, (No Diagnostic Substances)